No products in the cart.
Rybelsus® (semaglutide) will be the first ORAL GLP-1 agonist for type 2 diabetes…it’s a tablet version [...]
Mayzent® (siponimod) will be a new oral treatment for secondary progressive multiple sclerosis (MS) in adults. [...]
SGLT2 inhibitor (Jardiance®, Invokana®, Forxiga®, etc) risks are in the spotlight again. SGLT2 stands for [...]
The information contained in this evidence table is emerging and rapidly evolving because of ongoing [...]
Current treatment evidence of hydroxychloroquine in COVID-19
(April 14 2020) [...]
Irritable bowel syndrome (IBS) is the most commonly diagnosed gastrointestinal disorder.1,2 It affects more than one [...]
What are proton pump inhibitors? Proton pump inhibitors (PPIs) work by lowering the amount of [...]
Irritable bowel syndrome (IBS) affects more than one in ten people. People with IBS have [...]
Username or email address *
Log in Remember me
Lost your password?
Email address *